You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR LOCOID


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LOCOID

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00693693 ↗ Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis Completed Wake Forest University Phase 4 2006-11-01 The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.
NCT00871208 ↗ Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy Withdrawn GlaxoSmithKline Phase 4 2009-05-01 This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life.
NCT00871208 ↗ Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy Withdrawn St. Luke's-Roosevelt Hospital Center Phase 4 2009-05-01 This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life.
NCT02153762 ↗ Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream Completed Icahn School of Medicine at Mount Sinai N/A 2013-04-01 The purpose of this study is to evaluate the safety and tolerability, as well as effectiveness, with regards to the order of application for Locoid Lipocream and Hylatopic Plus cream in patients with atopic dermatitis (AD), which is a type of skin rash.Topical skin barrier repair therapies (BRT) that are plain moisturizing creams/lotions with added lipids (fats/oils), such as Hylatopic Plus cream, have emerged as an effective addition to the the treatment of atopic dermatitis. BRTs are often used along with topical steroids (medicated creams), such as Locoid lotion, on skin with AD, and as a monotherapy (single treatment) on both non-diseased and diseased skin. Since BRTs help to restore components of skin that are absent in skin with AD, it is believed that long-term BRT use may reduce further development of further AD. This is an open-label, single site study.
NCT02973776 ↗ Vasoconstriction Trial With LEO 90100 Aerosol Foam Completed LEO Pharma Phase 1 2016-12-01 Vasoconstriction study with LEO 90100
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LOCOID

Condition Name

Condition Name for LOCOID
Intervention Trials
Atopic Dermatitis 3
Psoriasis Vulgaris 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LOCOID
Intervention Trials
Eczema 3
Dermatitis, Atopic 3
Dermatitis 3
Psoriasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LOCOID

Trials by Country

Trials by Country for LOCOID
Location Trials
United States 3
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LOCOID
Location Trials
New York 2
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LOCOID

Clinical Trial Phase

Clinical Trial Phase for LOCOID
Clinical Trial Phase Trials
Phase 4 2
Phase 1 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LOCOID
Clinical Trial Phase Trials
Completed 3
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LOCOID

Sponsor Name

Sponsor Name for LOCOID
Sponsor Trials
Wake Forest University 1
GlaxoSmithKline 1
St. Luke's-Roosevelt Hospital Center 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LOCOID
Sponsor Trials
Other 3
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.